Cancer treatments hit EU markets months later than US: Rotterdam researcher

New medicines to treat cancer on average come onto the European market eight months later than they hit the United States market, according to a study by Professor Carin Uil-de Groot of Erasmus University Rotterdam. This is partly because the American authorities are much faster in registering new medicines, she concluded.Submitted by Janene Pieters on Saturday, 19 September 2020 - 08:15 https://nltimes.nl/2020/09/19/cancer-treatments-hit-eu-markets-months-later-us-rotterdam-researcher